These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 26938532)
41. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737 [TBL] [Abstract][Full Text] [Related]
42. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis. Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481 [TBL] [Abstract][Full Text] [Related]
43. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study. Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201 [TBL] [Abstract][Full Text] [Related]
45. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats. El-Swefy S; Hassanen SI Ann Hepatol; 2009; 8(1):41-9. PubMed ID: 19221533 [TBL] [Abstract][Full Text] [Related]
46. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. Jiang F; Parsons CJ; Stefanovic B J Hepatol; 2006 Sep; 45(3):401-9. PubMed ID: 16780995 [TBL] [Abstract][Full Text] [Related]
47. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470 [TBL] [Abstract][Full Text] [Related]
48. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498 [TBL] [Abstract][Full Text] [Related]
49. Liver-specific deletion of microRNA-34a alleviates ductular reaction and liver fibrosis during experimental cholestasis. Wan Y; Zhou T; Slevin E; Koyama S; Li X; Harrison K; Li T; Zhou B; Lorenzo SR; Zhang Y; Xu W; Klaunig JE; Wu C; Shetty AK; Huang CK; Meng F FASEB J; 2023 Feb; 37(2):e22731. PubMed ID: 36583714 [TBL] [Abstract][Full Text] [Related]
50. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice. Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605 [TBL] [Abstract][Full Text] [Related]
51. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver. Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586 [TBL] [Abstract][Full Text] [Related]
52. Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion. Yu X; Elfimova N; Müller M; Bachurski D; Koitzsch U; Drebber U; Mahabir E; Hansen HP; Friedman SL; Klein S; Dienes HP; Hösel M; Buettner R; Trebicka J; Kondylis V; Mannaerts I; Odenthal M Cell Mol Gastroenterol Hepatol; 2022; 13(6):1701-1716. PubMed ID: 35219894 [TBL] [Abstract][Full Text] [Related]
54. Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Zeng C; Wang YL; Xie C; Sang Y; Li TJ; Zhang M; Wang R; Zhang Q; Zheng L; Zhuang SM Oncotarget; 2015 May; 6(14):12224-33. PubMed ID: 25909171 [TBL] [Abstract][Full Text] [Related]
55. Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury. Zhang Y; Wu L; Wang Y; Zhang M; Li L; Zhu D; Li X; Gu H; Zhang CY; Zen K J Biol Chem; 2012 Apr; 287(18):14851-62. PubMed ID: 22393047 [TBL] [Abstract][Full Text] [Related]
56. MiR-29a and miR-652 Attenuate Liver Fibrosis by Inhibiting the Differentiation of CD4+ T Cells. Xuan J; Guo SL; Huang A; Xu HB; Shao M; Yang Y; Wen W Cell Struct Funct; 2017; 42(2):95-103. PubMed ID: 28768954 [TBL] [Abstract][Full Text] [Related]
57. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway. Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152 [TBL] [Abstract][Full Text] [Related]
58. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression. Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414 [TBL] [Abstract][Full Text] [Related]
60. Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. Marzioni M; Agostinelli L; Candelaresi C; Saccomanno S; De Minicis S; Maroni L; Mingarelli E; Rychlicki C; Trozzi L; Banales JM; Benedetti A; Baroni GS Hepatology; 2014 Oct; 60(4):1324-35. PubMed ID: 24925797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]